Improving the OPTN Policy Development Process Executive Committee Fall 2014.

Slides:



Advertisements
Similar presentations
Policy Oversight Committee (POC) Report OPTN/UNOS Board of Directors Yolanda Becker, MD, Chair Sue Dunn, RN, BSN, MBA, Vice Chair November 12-13, 2014.
Advertisements

Definition of a Transplant Hospital Membership and Professional Standards Committee Fall 2014.
Membership and Personnel Requirements for VCA Programs (Resolution 27) Vascularized Composite Allograft (VCA)Transplantation Committee Sue V. McDiarmid,
UNOS Update.  Updating 2012 Strategic plan  Planning for OPTN and UNOS Strategic Planning RegionsBoard Executive Committee /CAC Community.
Histocompatibility Bylaws Rewrite: Phase 2 Histocompatibility Committee Fall 2014.
Region 9 Meeting Lloyd Ratner, MD, MPH Regional Councillor.
Region 1 Meeting Heung Bae Kim, MD Regional Councillor.
Region 6 Meeting Viken Douzdjian, MD Regional Councillor.
November 12, 2014 St. Louis, Missouri OPTN Strategic Planning Feedback Board of Directors.
Proposal to Change the OPTN/UNOS Bylaws to Better Define Notification Requirements for Periods of Functional Inactivity Membership and Professional Standards.
Proposal to Clarify Data Submission Reporting and Documentation Requirements (Resolution 22) Membership & Professional Standards Committee (MPSC) Jonathan.
Greater Consistency in Candidate and Deceased Donor HLA Typing Requirements Across Organ Types Histocompatibility Committee Spring 2014.
Proposal to Require Reporting of Every Islet Infusion to the OPTN Contractor within 24 Hours of the Infusion Pancreas Transplantation Committee Fall 2012.
Policy Oversight Committee Update Board of Directors Meeting June 25-26, 2012 Stuart C. Sweet, MD, PhD.
UNOS Update Region 8 Kenneth Andreoni, M.D. OPTN/UNOS President April 4, 2014.
1 Region 10 Meeting Tim Taber, MD Regional Councillor.
Pediatric Training and Experience Requirements in the Bylaws OPTN/UNOS Board of Directors Eileen Brewer, MD, Chair William Mahle, MD, Vice Chair November.
Thoracic Organ Transplantation Committee Fall 2012 Public Comment Cycle.
1 Addressing the Term “Foreign Equivalent” in OPTN/UNOS Bylaws Membership and Professional Standards Committee Fall 2015.
Region 4 Meeting Kenneth Washburn, MD Regional Councillor.
Expanding HLA Typing Requirements (Resolution 10) Histocompatibility Committee Dolly Tyan, PhD Chair.
Membership & Professional Standards Committee (MPSC) Spring 2014.
1 Proposal to Increase Committee Terms to Three Years Policy Oversight Committee (POC) Fall 2015.
1 Proposal to Modify Pediatric Lung Allocation Policy Thoracic Organ Transplantation Committee Fall 2015.
Clarify Policy Language and Process for Individual Waiting Time Transfer Patient Affairs Committee Spring 2015.
Requiring Transplant Programs to Report in UNet℠ a Change in Criterion or Status within 24 Hours of that Change, and Other Edits Sponsored by the Thoracic.
Liver and Intestinal Organ Transplantation Committee Update David Mulligan, MD, Chair OPTN/UNOS Board of Directors Meeting November 12-13, 2014.
1 Membership and Professional Standards Committee Fall 2015.
Region 2 Meeting Michael Shapiro, MD.  Discuss regional business  Provide updates on OPTN/UNOS committee activities and projects  Discuss and comment.
1 Vascularized Composite Allograft (VCA) Transplantation Committee Fall 2015 Update.
Membership & Professional Standards Committee (MPSC)
Updating Primary Kidney Transplant Physician Requirements
Pediatric Transplantation Committee
Pediatric Transplantation Committee
Revisions to Pediatric Emergency Membership Exception
Membership & Professional Standards Committee (MPSC)
Vascularized Composite Allograft (VCA) Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Pediatric Transplantation Committee
Thoracic Organ Transplantation Committee
Membership and Professional Standards Committee
Histocompatibility Laboratory Bylaws and Policies Guidance Document
Histocompatibility Committee
Pediatric Transplantation Committee
Pediatric Transplantation Committee
OPTN/UNOS Thoracic Organ Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Membership & Professional Standards Committee
Updating the OPTN Definition of a Transplant Hospital
Pancreas Program Functional Inactivity
Thoracic Organ Transplantation Committee Spring 2019
Pediatric Transplantation Committee
Vascularized Composite Allograft (VCA) Transplantation Committee
Thoracic Organ Transplantation Committee
Executive Committee Update
Vascularized Composite Allograft (VCA) Transplantation Committee
Pediatric Transplantation Committee
Membership & Professional Standards Committee
Addressing Approved Transplant Fellowship Training Programs Bylaws
Membership & Professional Standards Committee Fall 2014
Vascularized Composite Allograft (VCA) Transplantation Committee
Imminent and Eligible Death Data Definitions Change Effective Date
Elizabeth A. Pomfret, MD, PhD Regional Councillor
Region 8 Meeting Harvey Solomon, MD
Vascularized Composite Allograft (VCA) Transplantation Committee
Fall 2012 Public Comment Cycle
Vascularized Composite Allograft (VCA) Transplantation Committee
VCA Committee Update Spring 2015.
Pediatric Transplantation Committee
OPTN/UNOS Histocompatibility Committee
Presentation transcript:

Improving the OPTN Policy Development Process Executive Committee Fall 2014

Key goal: Promote efficient management of the OPTN Objective: Improve responsiveness of OPTN policy to a changing environment OPTN Strategic Plan

 OPTN has ‘one size fits all’ process--no flexibility for solving different types of problems  Length of process has increased significantly in the last 5-7 years  can take 1.5 to 2 years to make even the simplest policy change Solution  Create two new policy development process tracks:  Emergency Actions  Expedited Actions The Problem

VCA Oversight Pediatric Lung Total Artificial Heart Emergency Actions Board is compelled to act before public comment and normal policy development process can be completed.

Limited to patient safety issues, statutory regulatory change that must be in place before public comment can be completed, or a new medical technology that affects organ allocation Board must specify a sunset date for the policy that is no more than 12 months after approval Policy must be distributed for public comment within 6 months of Board action Proposed New Process for Emergency Actions

Other routine updates LAS/CPRA algorithms Histo Bylaws Non-controversial Actions Non-controversial, routine changes are needed in a timely manner to be efficient

Proposed New Process for Non-Controversial Actions Sponsoring Committee distributes public comment proposal for new or existing policy and specifies policy sections that will be eligible for future expedited updates Board reviews and approves the policy including expedited process language At a later date, committee submits expedited proposal as stipulated by original policy. Expedited proposals require public comment of at least 30 days

No objections Policy changes take effect with notice to membership Possible Outcomes: Expedited Actions Objections from another committee, 5 members of public or 4 members of the Board Expedited process is not applicable. Proposal must follow normal development process #1 Some objections are received, but not enough to meet requirements in #2 above Sponsoring committee must present proposal to Executive Committee for review/approval #2 #3 _______________________________________________________________________

 Board review - June 2015  If approved, effective September 1, 2015 Expected Implementation

 Carl Berg, MD Committee Chair  Gena Boyle, MPA Policy Manager Questions?

Extra Slides

Length of Process Over Time (from project start to BOD)

Length of Process Over Time (length of public comment)

90 days for public comment (PC) period 240 days between PC distribution and BOD meeting days between PC upload and BOD meeting 480 days between POC committee project review and BOD meeting Currently, on average, there are…

Board Actions By Date